Multimodal Machine Learning Integrating Clinical and Proteomic Data for Early Prediction of Hypertensive Complications: A UKB Longitudinal Study
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.048151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Yuan Fei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Single-Cell Omics, School of Public Health Shanghai Jiao Tong University School of Medicine Shanghai China. Hauptthemen laut MEDLINE: Proteomics, Hypertension, Machine Learning, Kidney Diseases. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Hypertension is a leading risk factor for cardiovascular, cerebrovascular, and renal diseases, significantly worsening prognosis and quality of life. We aimed to develop and validate multimodal machine learning models integrating clinical and proteomic features for early prediction of hypertensive complications.
Methods
We analyzed 502 166 participants from the UKB (UK Biobank). Proteomic profiling was performed using the Olink Explore platform. Clinical variables and complication outcomes were obtained from electronic health records. Features were selected using Cox proportional hazards models and light gradient boosting machine classifiers. Multimodal predictive models were constructed using random forest, with Shapley Additive Explanations applied for model interpretation.
Results
During follow‐up, 1232, 166, and 549 participants developed heart, brain, and kidney complications, respectively. Among 3244 candidate features, 774, 600, and 1227 were associated with these outcomes. The integrated models achieved an area under the curve of 0.73 (95% CI, 0.68–0.77) for heart disease, 0.83 (95% CI, 0.73–0.92) for brain disease, and 0.79 (95% CI, 0.73–0.85) for kidney disease. Growth/differentiation factor 15 (hazard ratio [HR], 2.16 [95% CI, 1.93–2.42]), adaptor protein 3 complex subunit σ‐2 (HR, 0.57 [95% CI, 0.42–0.78]), and tumor necrosis factor receptor superfamily member 10B (HR, 4.06 [95% CI, 3.40–4.85]) were significantly associated with their respective complications, effectively predicting the risk of clinical progression (all P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Single-Cell Omics, School of Public Health Shanghai Jiao Tong University School of Medicine Shanghai China.
- School of Public Health Zunyi Medical University Zunyi Guizhou China.
- Hainan International Medical Center Shanghai Jiao Tong University School of Medicine Hainan China.
- Nossal Institute for Global Health, School of Population and Global Health The University of Melbourne Melbourne Victoria Australia.
- Key Laboratory of Maternal and Child Health and Exposure Science Guizhou Provincial Department of Education Zunyi Guizhou China.
ORCID-Profile: Siwei Liu, Jun Liu, Xiaoqi Zheng
Zitieren
APA
Fei, Y., Liu, S., Tong, T., Zhang, X., Wang, H., Liu, J., & Zheng, X. (2026). Multimodal Machine Learning Integrating Clinical and Proteomic Data for Early Prediction of Hypertensive Complications: A UKB Longitudinal Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.048151
Vancouver
Fei Y, Liu S, Tong T, Zhang X, Wang H, Liu J, et al. Multimodal Machine Learning Integrating Clinical and Proteomic Data for Early Prediction of Hypertensive Complications: A UKB Longitudinal Study. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.048151
BibTeX
@article{Fei2026,
author = {Fei, Yuan and Liu, Siwei and Tong, Tianlang and Zhang, Xuemei and Wang, Hui and Liu, Jun and Zheng, Xiaoqi},
title = {Multimodal Machine Learning Integrating Clinical and Proteomic Data for Early Prediction of Hypertensive Complications: A UKB Longitudinal Study},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.048151}
}
EUVIMED